Insider holders · CIK 0000861838
IDERA PHARMACEUTICALS, INC. · IDRA
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Pillar Pharmaceuticals V LPDirector | 875,000 | — | 875,000 | Oct 12, 2016 · 6:26 pm EDT | Form 3 |
| Youssef El ZeinDirector | 539,410 | 0 | 539,410 | Oct 17, 2017 · 5:10 pm EDT | Form 4/A |
| Vincent MilanoPresident & CEO | 89,566 | — | 89,566 | Jan 7, 2019 · 8:11 pm EST | Form 4 |
| Baker Bros. Advisors (GP) LLCDirector | — | 85,072 | 85,072 | Jan 4, 2019 · 4:52 pm EST | Form 4 |
| 667, L.P.Director | — | 85,072 | 85,072 | Jan 4, 2019 · 4:52 pm EST | Form 4 |
| 14159, L.P.Director | — | 85,072 | 85,072 | Jan 4, 2019 · 4:52 pm EST | Form 4 |
| Baker Brothers Life Sciences LPDirector | — | 85,072 | 85,072 | Jan 4, 2019 · 4:52 pm EST | Form 4 |
| BAKER BROS. ADVISORS LPDirector | — | 85,072 | 85,072 | Jan 4, 2019 · 4:52 pm EST | Form 4 |
| Felix BakerDirector | — | 85,072 | 85,072 | Jan 4, 2019 · 4:52 pm EST | Form 4 |
| Julian BakerDirector | — | 85,072 | 85,072 | Jan 4, 2019 · 4:52 pm EST | Form 4 |
| James A GeraghtyDirector | 65,433 | — | 65,433 | Aug 8, 2018 · 7:35 pm EDT | Form 4 |
| Mark J CaseySenior VP & General Counsel | 34,450 | — | 34,450 | May 13, 2016 · 9:00 am EDT | Form 4 |
| William S ReardonDirector | 32,973 | — | 32,973 | Jul 7, 2017 · 11:01 am EDT | Form 4 |
| Bryant David LimSVP and General Counsel | 22,843 | — | 22,843 | Jan 7, 2019 · 8:14 pm EST | Form 4 |
| Joanna HorobinChief Medical Officer | 20,144 | — | 20,144 | Jan 7, 2019 · 8:24 pm EST | Form 4 |
| Jonathan Michael YinglingChief Scientific Officer | 18,100 | — | 18,100 | Jan 7, 2019 · 8:29 pm EST | Form 4 |
| Robert C. FletcherSr. VP, Bus. Dev. & Strategy | 18,100 | — | 18,100 | Jan 7, 2019 · 8:22 pm EST | Form 4 |
| John J. KirbyVP of Finance | 12,509 | — | 12,509 | Jan 7, 2019 · 8:17 pm EST | Form 4 |
| Mark Alan GoldbergDirector | 10,000 | — | 10,000 | Dec 20, 2018 · 5:26 pm EST | Form 4 |
| Carol SchaferDirector | 5,000 | — | 5,000 | Dec 20, 2018 · 5:25 pm EST | Form 4 |
| Howard H PienDirector | 2,929 | — | 2,929 | Jan 3, 2019 · 4:41 pm EST | Form 4 |
| Maxine GowenDirector | 1 | — | 1 | Jun 9, 2017 · 4:15 pm EDT | Form 5 |
| Pillar Pharmaceuticals IV, L.P.Director | — | 0 | 0 | Dec 17, 2015 · 6:38 pm EST | Form 4 |
| Pillar Pharmaceuticals III, L.P.10% Owner | — | 0 | 0 | Aug 17, 2018 · 5:44 pm EDT | Form 4 |
| Pillar Pharmaceuticals II, L.P.10% Owner | — | 0 | 0 | Aug 17, 2018 · 5:44 pm EDT | Form 4 |
| Pillar Invest Corp10% Owner | — | 0 | 0 | Aug 17, 2018 · 5:44 pm EDT | Form 4 |
| Pillar Pharmaceuticals I LP10% Owner | — | 0 | 0 | Aug 17, 2018 · 5:44 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.